You are here: Industry Insights > hepatitis C

News List

Hep C cases down around 70% in HIV positive men in London and Brighton pharmatimes
March 26, 2020
An analysis of five clinics in London and Brighton has revealed that new cases of hepatitis C amongst HIV positive men in the areas have fallen by nearly 70% in recent years.
FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C fda
March 20, 2020
The U.S. Food and Drug Administration today approved a supplemental application for Epclusa (sofosbuvir and velpatasvir) to treat hepatitis C virus (HCV) in children ages 6 years and older or weighing at least 37 pounds (17 kilograms) with any of the six
Heart Transplants From Donors With Hepatitis C May Be Safe drugs
January 14, 2020
One-year survival rates are similar for transplant patients who receive a heart from a donor with hepatitis C or one without the infectious virus, a new study finds.
Kidney Transplants Safe When Donors Had Hepatitis C drugs
September 16, 2019
Kidneys from donors with the hepatitis C virus (HCV) are routinely used in kidney transplants in the United States and function well in the first year after transplantation, a new study says.
Test All U.S. Adults for Hepatitis C, Expert Panel Says drugs
August 28, 2019
Hepatitis C infection rates have exploded in the United States, more than tripling over the past decade.
Cure Hepatitis C in 8 Weeks: Maviret, the Hepatitis C Drug with the Best Efficacy in the World, has Entered China PharmaSources/1℃
June 04, 2019
The National Medical Products Administration of China (NMPA) has approved the marketing of AbbVie’s direct-acting antiviral (DAA) Maviret (glecaprevir/pibrentasvir) on May 15, 2019.
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck fiercepharma
March 08, 2019
States across the U.S. have taken on high drug prices with new laws, proposals and Medicaid rules, many of them unpopular with the pharma industry.
Court backs NHS in hepatitis C procurement row with AbbVie pharmaphorum
January 22, 2019
A court has backed NHS England in a case where US pharma giant AbbVie had alleged that its procurement process for hepatitis C drugs was unfair.
Hepatitis C Screening Can Help Prevent Liver Disease drugs
January 04, 2019
Infection with the hepatitis C virus can cause liver disease and even liver cancer. But once found, the virus can be cured, so screening is vital for those at risk, health experts say.......
Genentech buys NASH biotech Jecure pharmaphorum
November 30, 2018
Roche’s Genentech unit has bought California biotech Jecure Therapeutics, which is researching drugs that could be used in inflammatory diseases including the fatty liver disease NASH.

Previous page 1 2 3 Next page